Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005970
Status:
COMPLETED
Last Update Posted:
2020-08-14
First Post:
2000-07-05
Brief Title:
Doxorubicin Hydrochloride Cyclophosphamide and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IIIA Breast Cancer AJCC v7 |
| Breast Adenocarcinoma |
| HER2 Positive Breast Carcinoma |
| Stage IA Breast Cancer AJCC v7 |
| Stage IB Breast Cancer AJCC v7 |
| Stage IIA Breast Cancer AJCC v6 and v7 |
| Stage IIB Breast Cancer AJCC v6 and v7 |
Keywords: